tiprankstipranks
Trending News
More News >
Sotera Health (SHC)
NASDAQ:SHC
US Market

Sotera Health (SHC) Earnings Dates, Call Summary & Reports

Compare
165 Followers

Earnings Data

Report Date
Aug 06, 2025
TBA Not Confirmed
Period Ending
2025 (Q2)
Consensus EPS Forecast
0.17
Last Year’s EPS
0.19
Same Quarter Last Year
Based on 5 Analysts Ratings

Earnings Call Summary

Earnings Call Date:May 01, 2025
|
% Change Since: 7.30%
|
Next Earnings Date:Aug 06, 2025
Earnings Call Sentiment|Positive
Sotera Health demonstrated robust growth in revenues and EBITDA, notably in Nelson Labs and Nordion, and maintained a positive outlook for 2025. However, challenges such as the Cobalt-60 shipment timing, a GAAP net loss due to legal settlements, and revenue decline in Nelson Labs advisory services were noted. Despite these lowlights, the positive developments and reaffirmed growth outlook suggest a resilient performance.
Company Guidance
During the first quarter of 2025 earnings call, Sotera Health provided guidance indicating a strong start to the year, with revenue increasing by 2.6% or 4.4% on a constant currency basis compared to Q1 2024. The company reported an adjusted EBITDA growth of 8.8% or 11.2% on a constant currency basis. The adjusted EPS for the quarter was $0.14, showing a $0.01 improvement from the previous year. Sotera reaffirmed their full-year 2025 outlook, expecting revenue growth between 4% to 6% and adjusted EBITDA growth of 4.5% to 6.5% on a constant currency basis. The company anticipates a foreign exchange headwind of approximately 1.25% on revenue and 1.5% on adjusted EBITDA. Additionally, Sotera expects a net leverage ratio improvement, with capital expenditures projected between $190 million to $210 million for 2025, and a goal to generate $500 million to $600 million in free cash flow over the next three years.
Solid Start to 2025 with Revenue and EBITDA Growth
Sotera Health reported a 2.6% increase in total company revenues, or 4.4% on a constant currency basis, for Q1 2025 compared to Q1 2024. Adjusted EBITDA increased by 8.8%, or 11.2% on a constant currency basis.
Nelson Labs Margin Expansion
Nelson Labs achieved a 479 basis point margin expansion versus Q1 2024, marking the third consecutive quarter of year-over-year margin expansion.
Nordion's Strong Revenue Performance
Nordion's revenue increased by 36% to $33 million, or 40.6% on a constant currency basis, compared to Q1 2024. Segment income increased approximately 62%.
Reaffirmed 2025 Outlook
Sotera Health reaffirmed its 2025 outlook, expecting revenue growth in the range of 4% to 6% and adjusted EBITDA growth of 4.5% to 6.5% on a constant currency basis.
Successful Amendment to Revolving Credit Facility
The amendment added approximately $175 million in liquidity, extending maturity to April 2030.
FDA Clearance for Bionic Pancreas
Sotera Health played a critical role in securing FDA clearance for the first-ever bionic pancreas, showcasing the integrated expertise of Nelson Labs and Sterigenics.

Sotera Health (SHC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

SHC Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 06, 2025
2025 (Q2)
0.17 / -
0.19
May 01, 2025
2025 (Q1)
0.12 / 0.14
0.137.69% (+0.01)
Feb 27, 2025
2024 (Q4)
0.20 / 0.21
0.26-19.23% (-0.05)
Nov 05, 2024
2024 (Q3)
0.18 / 0.17
0.21-19.05% (-0.04)
Aug 05, 2024
2024 (Q2)
0.17 / 0.19
0.21-9.52% (-0.02)
May 02, 2024
2024 (Q1)
0.12 / 0.13
0.130.00% (0.00)
Feb 27, 2024
2023 (Q4)
0.26 / 0.26
0.254.00% (+0.01)
Nov 01, 2023
2023 (Q3)
0.20 / 0.21
0.23-8.70% (-0.02)
Aug 03, 2023
2023 (Q2)
0.18 / 0.21
0.27-22.22% (-0.06)
May 03, 2023
2023 (Q1)
0.14 / 0.13
0.22-40.91% (-0.09)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

SHC Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 01, 2025
$11.50$12.10+5.22%
Feb 27, 2025
$13.64$12.28-9.97%
Nov 05, 2024
$15.80$15.42-2.41%
Aug 05, 2024
$13.22$14.22+7.56%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Sotera Health (SHC) report earnings?
Sotera Health (SHC) is schdueled to report earning on Aug 06, 2025, TBA Not Confirmed.
    What is Sotera Health (SHC) earnings time?
    Sotera Health (SHC) earnings time is at Aug 06, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is SHC EPS forecast?
          SHC EPS forecast for the fiscal quarter 2025 (Q2) is 0.17.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis